| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2265.2007.03126.X |
| P698 | PubMed publication ID | 18031326 |
| P50 | author | Anita Hokken-Koelega | Q110439807 |
| P2093 | author name string | Böhm B | |
| Duivenvoorden HJ | |||
| Lindgren AC | |||
| Wit JM | |||
| Wevers M | |||
| Otten BJ | |||
| Festen DA | |||
| P2860 | cites work | Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS. | Q30979832 |
| Genomic imprinting and uniparental disomy in Angelman and Prader-Willi syndromes: a review | Q40854024 | ||
| Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index | Q47378732 | ||
| Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome | Q47596413 | ||
| Critical periods of brain growth and cognitive function in children | Q48133998 | ||
| Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment | Q48489602 | ||
| Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy. | Q51479493 | ||
| The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study. | Q51960056 | ||
| Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. | Q53743219 | ||
| P433 | issue | 6 | |
| P921 | main subject | toddler | Q1340307 |
| P304 | page(s) | 919-925 | |
| P577 | publication date | 2007-11-19 | |
| P1433 | published in | Clinical Endocrinology | Q15762781 |
| P1476 | title | Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome. | |
| P478 | volume | 68 |
| Q57496443 | A Novel Mutation of in a Patient with Schaaf-Yang Syndrome and Hypopituitarism |
| Q38683122 | Aberrant White Matter Microstructure in Children and Adolescents With the Subtype of Prader-Willi Syndrome at High Risk for Psychosis |
| Q37708438 | Altered functional resting-state hypothalamic connectivity and abnormal pituitary morphology in children with Prader-Willi syndrome |
| Q50613774 | Behavior in children with Prader-Willi syndrome before and during growth hormone treatment: a randomized controlled trial and 8-year longitudinal study. |
| Q33726997 | Certainty of genuine treatment increases drug responses among intellectually disabled patients |
| Q33868078 | Clinical management of behavioral characteristics of Prader-Willi syndrome |
| Q33825517 | Clinically important age-related differences in sleep related disordered breathing in infants and children with Prader-Willi Syndrome |
| Q38835532 | Cognitive and adaptive advantages of growth hormone treatment in children with Prader-Willi syndrome |
| Q90657261 | Contributing factors of mortality in Prader-Willi syndrome |
| Q33590026 | Divergent structural brain abnormalities between different genetic subtypes of children with Prader-Willi syndrome |
| Q64990538 | EFFECT OF GROWTH HORMONE THERAPY IN CHILDREN WITH PRADER-WILLI SYNDROME - OUR FIRST EXPERIENCES. |
| Q33851054 | Early diagnosis and care is achieved but should be improved in infants with Prader-Willi syndrome |
| Q42367372 | Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial |
| Q90066670 | Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial |
| Q21245401 | Endocrine manifestations and management of Prader-Willi syndrome |
| Q36116895 | Endocrine problems in children with Prader-Willi syndrome: special review on associated genetic aspects and early growth hormone treatment |
| Q38286211 | Growth hormone secretion decreases with age in paediatric Prader-Willi syndrome |
| Q51786199 | Growth hormone treatment improves vitality and behavioural issues in children with Prader-Willi syndrome. |
| Q37955825 | Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study |
| Q33726962 | Growth hormone treatment in non-growth hormone-deficient children |
| Q37213617 | GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome |
| Q90577544 | Hypermobility in individuals with Kabuki syndrome: The effect of growth hormone treatment |
| Q38115642 | Long-term effects of recombinant human growth hormone therapy in children with Prader-Willi syndrome |
| Q51277400 | Metabolic health profile in young adults with Prader-Willi syndrome: results of a 2-year randomized, placebo-controlled, crossover GH trial. |
| Q37807643 | Motor problems in Prader–Willi syndrome: A systematic review on body composition and neuromuscular functioning |
| Q52649236 | Neonatal Features of The Prader-Willi Syndrome; The Case for Making The Diagnosis During The First Week of Life. |
| Q50434991 | Neuropsychiatric aspects of Prader-Willi syndrome – a Review |
| Q58571446 | PRADER-WILLI SYNDROME: WHAT IS THE GENERAL PEDIATRICIAN SUPPOSED TO DO? - A REVIEW |
| Q35680723 | Prader-Willi syndrome and autism spectrum disorders: an evolving story |
| Q34077985 | Prader-Willi syndrome and growth hormone deficiency |
| Q43622305 | Prader-Willi syndrome and growth hormone treatment |
| Q36099265 | Prader-Willi syndrome in neonates: twenty cases and review of the literature in Southern China |
| Q35554826 | Prader-Willi syndrome: A primer for clinicians |
| Q36240989 | Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings |
| Q34022930 | Prader-Willi syndrome: a single center's experience in Korea |
| Q26827423 | Prader-Willi, Angelman, and 15q11-q13 Duplication Syndromes |
| Q58493440 | Prader–Willi syndrome and growth hormone treatment in children and adults |
| Q93024196 | Prevalence of growth hormone (GH) deficiency in previously GH-treated young adults with Prader-Willi syndrome |
| Q34195542 | Reduced cortical complexity in children with Prader-Willi Syndrome and its association with cognitive impairment and developmental delay |
| Q53103501 | Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis. |
| Q38925660 | Rigidity in routines and the development of resistance to change in individuals with Prader-Willi syndrome. |
| Q37389115 | Sleep disordered breathing in infants with Prader-Willi syndrome during the first 6 weeks of growth hormone therapy: a pilot study. |
| Q34799188 | Systematic review of the clinical and genetic aspects of Prader-Willi syndrome |
| Q50567527 | Visual-motor integration in children with Prader-Willi syndrome. |
| Q38155729 | What is the value of growth hormone therapy in Prader Willi syndrome? |
| Q50554617 | [Prader-Willi syndrome in 2015]. |
Search more.